chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a non-contactable consumer (patient). A 29-years-old non pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: Er8736) via an unspecified route of administration, administered in arm left on 28Apr2021 at 15:45 (at the age of 29-years-old) as dose 2, single for covid-19 immunization. The patient was not pregnant at time of vaccination. Patient medical history included known allergies with sulfa medication from an unknown date and unknown if ongoing. Concomitant medications was not reported. Patient had not received any other vaccine in four weeks and other medications in two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Historical vaccine included received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: Ew0158), via an unspecified route of administration, administered in arm left on 07Apr2021 at 15:45 as dose 1, single for covid-19 immunization and experienced sore arm at injection site. On 29Apr2021, the patient experienced sore arm with small lump at injection site, full body ache as the day progressed, chills. On 29Apr2021, at 15:45, the patient experienced fever. The patient noticed when she woke up the next day, she developed fever, chills and full body ache as the day progressed. Fever broke at 15:45 (24 hours after getting vaccine). The patient did not receive any treatment for the events. The outcome of events was recovering. No follow-up attempts are possible. No further information is expected.
injection site is itchy; injection site has a 3 inch red spot.; A spontaneous report was received from a consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events injection site is itchy, injection site has a 3 inch red spot,  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 6 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) injection site is itchy, injection site has a 3 inch red spot.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), injection site is itchy, injection site has a 3 inch red spot,  was unknown.
Pain and numbness on L side of body. Specifically arthritis type pain in knee and hand.
Chest pain , fever , breathing issues ,  migraines that didn't respond to meds  two rd visits.  Five day migraine and ongoing breathing issues at time over two weeks later.  Dehydration
body aches; chills; like having the flu; This is a spontaneous report from a contactable consumer reporting for a female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number, Expiration date: unknown) via an unspecified route of administration on an unknown date at single dose for COVID-19 Immunization. The patient's medical history included first dose of COVID vaccine. Concomitant medication was not reported. On an unknown date patient experienced body aches and chills, would not have able to go to work, like having the flu. The patient treatment reported as unknown. The event assessed as non-serious by the reporter. The outcome for the event was unknown.  Information on the lot/batch number has been requested.
every bone in my body hurts, down to my ankles; both her and her husband don't feel like themselves.; temperature of 99.6 for two days; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (every bone in my body hurts, down to my ankles), FEELING ABNORMAL (both her and her husband don't feel like themselves.) and PYREXIA (temperature of 99.6 for two days) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concomitant products included CARBIDOPA, LEVODOPA (CARBIDOPA/LEVODOPA), GABAPENTIN, CARVEDILOL, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), DULOXETINE, FENOFIBRATE, TOLTERODINE L-TARTRATE (TOLTERODIN), PRAVASTATIN and ACETYLSALICYLIC ACID (ASPIRIN) for an unknown indication.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PYREXIA (temperature of 99.6 for two days). On an unknown date, the patient experienced BONE PAIN (every bone in my body hurts, down to my ankles) and FEELING ABNORMAL (both her and her husband don't feel like themselves.). On 01-Mar-2021, PYREXIA (temperature of 99.6 for two days) had resolved. At the time of the report, BONE PAIN (every bone in my body hurts, down to my ankles) and FEELING ABNORMAL (both her and her husband don't feel like themselves.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.6 (Inconclusive) 99.6.         Action taken with mRNA-1273 in response to the events was not Applicable.
completely lethargic; couldn't move; headache; pain in her joints; fatigued; slightly elevated fever like over 99 less than 100; sugar has been elevated and it's spiking up and down; This is a spontaneous report from a contactable consumer (daughter). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EL8982, second dose) solution for injection on 06Feb2021 at 16:00 (at an unknown age) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (Lot EL8982, first dose) for COVID-19 immunisation on 16Jan2021 and experienced shaking and pain in your arm. The patient had the second shot on Saturday, 06Feb2021, and at 8pm she had a headache, pain in her joints, was fatigued, had a slightly elevated fever like over 99 less than 100. Then on 07Feb2021, she could not get out of bed, completely lethargic, fatigued, couldn't move really was in bed for almost a full day and a half. Now the concern was her sugar has been elevated and it's spiking up and down this entire week in Feb2021. The outcome of the events headache, pain in her joints, fatigued, fever, completely lethargic, couldn't move and blood sugar level fluctuation was unknown.
rapid heart rate; anxiety; This is a spontaneous report from a contactable nurse reported for nephew from a Pfizer-sponsored program.  A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient received by the Pfizer Covid vaccine and was now complaining of rapid heart rate. He had never had anything like this happen before. The patient had been transported to the hospital 5 times as a result of his symptoms and all cardiac workup tests had resulted negative for cardia issues. The doctor said its anxiety but it is not anxiety. They put the patient on a blood pressure medicine for his high heart rate. Reporter was concerned that the patient was being treated for anxiety rather than treating this a symptom due to lack of knowledge about the side effects of the Pfizer covid vaccine. The patient was in the hospital right now. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The causal relationship between BNT162B2 and the  reported events cannot be excluded  based on temporal relationship. The information available in this report is limited. Of note, medical history and concomitant medications were not provided. Case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Patient seen on 03/03/2006 left leg red, swollen, warm to touch.  Patient's leg sore.  Became increasingly red/swollen- started on 03/02/2006 - worse 03/03/2006.  16 x 12 cm area redness/swelling.  Prescribed Zyrtec and Keflex.
first dose more than six months ago; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 88-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 17th October 2019, batch number 5k99).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule. The reporter consented to follow up. This case had been linked with case US2021AMR210168, reported by the same reporter.
I didn't get very sick with the first two injections. I was in bed for 36 hours after the third. My arm hurt like it would hurt after an injection- but that never went away. I started getting deep joint pain where I got the vaccine. I went back to see a doctor who I had seen for a shoulder injury previously with that shoulder. She didn't seem to think that my presentation was similar to what she had seen me for before. It was a deep aching shoulder pain. I couldn?t lay on that side. It didn't hurt to move my arm, but it was a deep aching pain deep within the shoulder joint. She scheduled me to go in for a steroid injection when I went to visit her on 11/18/2021, and she scheduled me for the following Tuesday. I never was able to get the steroid injection. The shoulder has progressively improved without the injection. Partially recovered.
05Nov90 pt vax w/ hepta B; exp transient joint pain. 14Dec90 vax w/ 2nd dose; devel severe joint pain in ankle, knees, hips, rt wrist, thumb.  Tx w/ Ansaid & Cytotec.    See worm...
Patient originally received Pfizer as her primary dose and thought she had gotten Moderna. So when she came to us for her 2nd dose she filled out consent with all Moderna, wishing to receive Moderna. When looked up in database after administration it was noticed that persons actually received Pfizer. Spoke to persons she is made aware. Spoke with Representative at health facility and she is not to do anything further she is considered fully vaccinated and may get whichever she would like as her booster 6 months after her 2nd dose which ended up being the Moderna. Verbiage of this clarification was also emailed to me. Patient called and notified. She is doing well and has had no adverse reaction.
Sudden onset of vague muscle pain in R trapezius and adjacent musculature with crescendo of pain to include entire trapezius and referred pain throughout the brachial plexus.
Sitting and felt dizzy. Sat on floor, pale and diaphoretic. Momentarily unconscious. 98/60 60 20. Gradually felt better. Took ice H2O and chips.
PATIENT RECEIVED A PFIZER BIVALENT BOOSTER ON 11/16/2022.  PATIENT RECEIVED ANOTHER MODERNA BIVALENT BOOSTER ON 12/8/2022.
This spontaneous report as received from a male patient of unknown age regarding himself. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. Approximately in 2016, the patient had been vaccinated with the second dose of GARDASIL 9 (dosing details, lot# and expiry date were not reported). It has been more than 6 months since the patient had received the second dose of GARDASIL 9. The PI indicated he should have received the third dose at six months. No adverse reactions were reported. There were no product quality complaints (PQC) involved. Additional information is not expected as reporter contact details were not provided.
14:27: Pt in chair flagged RN over. Reported feeling extremely nauseated. pale and sweating, thready pulse present . BP 140/78, HR 120. A+O x3 Upon questioning Pt mentioned that he did not eat today. 14:30 Water was provided and fruit gummies (15g sugar) . Patient presented 2 projectile emesis.  14:30 EMS was called. Patient wanted to leave home, but team was able to ask him to seat on the floor.  14:38 blood sugar =96 per medics after 15g of sugar.  14:45 Pt did not want to get checked at hospital. EMS left  Observed patient for 15 more minutes.  15:00 Pt left facility accompanied by uncle stable and oriented. Called pt by phone to check on him and mentioned feeling OK
Information has been received from a physician concerning a 7 year old male who on 12/28/2000 was vaccinated with a dose of varicella vaccine. On 09/06/2001, the pt tested negative for IGG antibody. The test result was 0.69, which was negative. The pt did not seek medical attention. Additional info has been requested.
After immunization of the 6th vaccine (HPV9), patient head rolled down, eyes closed, skin was pale and clammy , and she was  non- responsive. Immunization nurse  began stimulation tactics by calling out her name and holding her head. A few seconds in, Patient was aroused and was oriented x 2 (Name and Place). Vitals signs taken, Patient escorted to exam room, and was examined by Physician. Patient was discharged and left facility without further incident with ER precautions
The thimerosal in this vaccination caused mercury toxicity, eczema, chronic constipation, persistant ear infections, irritable bowel syndrome and autistic like behaviors. Vaccine data updated in VAERS per vax record.  Prevnar given on 5/16/03, not IPV.  10/23/2007 MR received for WCC on 2/14/2003 to 3/29/2005.  WCC on 2/14/03 with normal growth & dev however still walking with assistance at age 15 mon.  Child had seen opthomologist for eval of stabismus/pseudostrabismus. 18 mon WCC 5/16/03 shows only saying 4 words otherwise doing well.  Hearing eval 5/03 and myringotomy tubes placed 6/03.  TC with MD 8/27/03 re: autism.  MD advised to watch progression of speech and reassessment of skills now that pt is hearing well 2' to ear tubes.  Speech delay noted at 2yr WCC.  Speaks 3-5 words, no phrases. Receiving speech tx and early intervention. Multiple visits for ear issues-bleeding, drainage, OM. 3 yr check with developmental delay noted.  DX: Autistic Disorder. PDD. Refered to GI for constipation and stool withholding. See also 292955. Per 60 day follow up: Mercury toxicity, constant eczema, chronic constipation, irritable bowel syndrome, lack of speech, autism. 1/12/2010 Patient still has chronic constipation, constant eczema and exhitbits autistic like behaviors.
Site was itching x 1 week. No raised area. Received vaccine in left deltoid. Scratches on arm.
Flu like symptoms; aching joints, chills, tiredness, weakness, bad headache lasted 24 hours and was gone
Macular/Papular rash, non-pruritic, over trunk, back and both upper extremities.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 76-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 76 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient has not received any other medication in 2 weeks.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal relationship between the events drug ineffective, covid-19 and suspect drug BNT162B2 cannot be excluded.
I use a menstrual cycle tracking app.   In January,  I had a heavier than normal period but it was on time.   In February, period was heavier than normal but on time.   In March, I noted Blood color and smell, thin and runny... leaked twice today, really heavy.  In April,  I experienced constipation, diarrhea, and cramps in the days leading up to my period which I don?t normally experience.  In May,  I experienced dark blood or brown discharge the first day of period.  In June, I experienced a migraine, neck ache, and period was two days longer than usual.  In July,  my period started two days early.  And in August, the biggest reason I?m reporting is I spotted for three days and that was all for my period.  None of this has ever happened before.
On 4/5 I had discharge out of my left ear. On 4/9 I had to see an after hours doctor who said there was an abscess. There was a hole and pus, and blood were coming out. The left side of my neck was swollen. I also had pain in my neck and behind both my ears and inside my ears. On 4/13 I had to go to an after hours care because I had sudden onset nerve pain in my left lower back. It felt like sciatica. My pain level was a 9.5/10. I was given a cortisone shot which helped. On 4/16 I went to an ENT where I did an CT scan on my left side because my neck was still was still swollen. He did say my ear was healing. I was also sent to physical therapy which helped a little. On 4/18, I noticed that my right wrist carpal tunnel flared up. My right wrist became enflamed and my right upper arm began hurting. The lower back pain also became enflamed. The left side of my face hurt and inside my left ear, around the cartilage I had another sore. I also was experiencing a dry mouth.
Chills; Pain in hips; Cramping in abdomen; Pain in left ear; This is a spontaneous report from a contactable consumer(patient) reported that. A 48-years-old female patient started to receive bnt162b2 (BNT162B2Formualation:Solution for injection ) ,via an unspecified route of administration from 28Jan2021 14:45 to 28Jan2021 14:45 at SINGLE DOSE for an unspecified indication .Medical history included sialadenosis from an unknown date and unknown if ongoing , cervix carcinoma from an unknown date and unknown if ongoing , covid-19 from an unknown date and unknown if ongoing If covid prior vaccination: Yes.  The patient's concomitant medications were not reported. The patient experienced chills on 28Jan2021 19:00 , pain in hips on 28Jan2021 19:00 cramping in abdomen on 28Jan2021 19:00  pain in left ear on 28Jan2021 19:00 and  The patient underwent lab tests and procedures which included body temperature: 97.3 on  Temperature under the tongue was 97.3 and outcome of the events was unknown   Information on the Lot/Batch number has been requested.
Affected thyroid, swollen lymph nodes, muscle burn and weakness, hormonal imbalance, bloating, lethargy, mental confusion and memory loss, shortness of breath, exhaustion, stiff spine and joint pain.
4 days after dose 2 had red itchy arm at site of shot.  6 days after shot had slight dizziness in the morning. 7 days after shot had diarrhea and slight headache
PATIENT RECEIVED ADULT DOSE (PURPLE CAP) AS FIRST DOSE IN SERIES WHEN THE PATIENT SHOULD HAVE BEEN ADMINISTERED PEDIATRIC DOSE (ORANGE CAP) AS FIRST DOSE
I got joint pain that seemed to subside after about 10 days. A few days after my second dose it returned, and never fully went away from my elbows. Both elbows still hurt/ache nearly all the time, not badly, but noticably.
Not feeling good; Patient is not healthy; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (hospitalization), outcome "unknown", described as "Not feeling good"; ILLNESS (non-serious), outcome "unknown", described as "Patient is not healthy". Therapeutic measures were not taken as a result of malaise. Additional information: the reporter (patient's daughter) stated that the doctor cannot give the patient the treatment, the patient was not healthy and she just not feeling good right now.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Hospitalization for hypoxemia due to COVID on dates 7/3/2022-7/772022. Treated with dexamethasone, baricitinib, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Woke up on 10/1 totally deaf in my left hear. Saw primary doctor and then went to ENT to get diagnosed. Started treatment
Narrative:  She notes having experienced right-sided axillary pain (same side as vaccination) a/w enlarged LN starting the evening of the vaccination and lasting for 4x days. It was intially a/w headache that evening as well. No other adverse  effects were noted and she denies having increased sensitivity to past vaccinations. No therapies were tried or applied and the issues spontaneously  resolved.
Chest pains after the 1st dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of CHEST PAIN (Chest pains after the 1st dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-May-2021, the patient experienced CHEST PAIN (Chest pains after the 1st dose). At the time of the report, CHEST PAIN (Chest pains after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Moderna on 2/10 and 3/11. Positive on 11/7.
Redness, Swelling, Vomiting , fatigue, aggravated chronic lower back pain.  Patient use ice compress for redness and swelling.
This spontaneous report as received from a pharmacist via a company representative refers to a 63 years old female patient. On 13-APR-2014 the patient was vaccinated with ZOSTAVAX, 0.65ml, lot # J007211, expiration date 20-SEP-2014, subcutaneous. On 13-APR-2014 the patient experienced developed a "round yellow red patch" at the injection site. The patient informed the pharmacist in person of the injection site reaction on 13-APR-2014. The pharmacist informed the patient to apply ice and take TYLENOL. The outcome of the event was reported as recovering/resolving. The patient had sought medical attention. Additional information has been requested.